Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Metastatic Neuroendocrine Prostate Cancer 1Meningioma 1Adenocarcinoma, Follicular 1

Interventions

Magnetic Resonance Spectroscopy 5Specimen Handling 4Nivolumab 3ulixertinib 2dabrafenib 2binimetinib 2Surveys and Questionnaires 2Sunitinib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2Cetuximab 2CTLA-4 Antigen 2Biopsy 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1temsirolimus 1selpercatinib 1sapanisertib 1repotrectinib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × gallium Ga 68 dotatate × 30 days × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡